These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 28889238

  • 1. Langerhans cell histiocytosis and Erdheim-Chester disease overlap syndrome with bone marrow involvement and type 2 diabetes mellitus.
    Chen M, Ding C, Lu T, Niu N, Han B.
    Ann Hematol; 2018 Jan; 97(1):189-192. PubMed ID: 28889238
    [No Abstract] [Full Text] [Related]

  • 2. Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis.
    Ocak S, Bayramoglu Z, Tugcu D, Karaman S, Unuvar A, Karakas Z.
    J Pediatr Hematol Oncol; 2021 Apr 01; 43(3):e375-e379. PubMed ID: 32097280
    [Abstract] [Full Text] [Related]

  • 3. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
    Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, Cluzel P, Drier A, Hervier B, Benameur N, Besnard S, Donadieu J, Amoura Z.
    Blood; 2013 Feb 28; 121(9):1495-500. PubMed ID: 23258922
    [Abstract] [Full Text] [Related]

  • 4. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
    Hao X, Feng R, Bi Y, Liu Y, Li C, Lu T, Tian Y.
    J Neurosurg Pediatr; 2019 Jan 01; 23(1):48-53. PubMed ID: 30265230
    [Abstract] [Full Text] [Related]

  • 5. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J.
    Curr Oncol Rep; 2019 May 21; 21(7):62. PubMed ID: 31115724
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
    Johnson WT, Patel P, Hernandez A, Grandinetti LM, Huen AC, Marks S, Ho J, Monaco SE, Jaffe R, Picarsic J.
    J Cutan Pathol; 2016 Mar 21; 43(3):270-5. PubMed ID: 26454140
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histopathological and Clinical Findings in Cutaneous Manifestation of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome Associated With the BRAFV600E Mutation.
    Liersch J, Carlson JA, Schaller J.
    Am J Dermatopathol; 2017 Jul 21; 39(7):493-503. PubMed ID: 27898473
    [Abstract] [Full Text] [Related]

  • 11. [Langerhans cell histiocytosis and Erdheim-Chester disease, a continuity?].
    Parreau S, Haroche J, Pommepuy I, Emile JF, Bourras JC, Archambeaud F.
    Rev Med Interne; 2017 Jul 21; 38(7):482-487. PubMed ID: 27889325
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease.
    Cao XX, Niu N, Sun J, Zhou DB, Li J.
    Ann Hematol; 2018 Jan 21; 97(1):185-187. PubMed ID: 28831599
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J, Cohen-Aubart F, Charlotte F, Maksud P, Grenier PA, Cluzel P, Mathian A, Emile JF, Amoura Z.
    Expert Rev Clin Immunol; 2015 Jan 21; 11(9):1033-42. PubMed ID: 26197238
    [Abstract] [Full Text] [Related]

  • 15. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A, Ferrario G, Parafioriti A, Giardino D, Simonetti F, Ginori A, Passoni E, Berti E, for AIRI, Associazione Italiana Ricerca Istiocitosi ONLUS.
    J Cutan Pathol; 2021 May 21; 48(5):637-643. PubMed ID: 33188581
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effective High-dose Interferon-α Therapy in a 13-Year-Old Girl With Erdheim-Chester Disease.
    Tezol O, Citak EC, Ayhan YS, Balci Y, Koc ZP, Yuyucu Karabulut Y.
    J Pediatr Hematol Oncol; 2020 May 21; 42(4):326-331. PubMed ID: 31259822
    [Abstract] [Full Text] [Related]

  • 19. A common progenitor cell in LCH and ECD.
    Badalian-Very G.
    Blood; 2014 Aug 14; 124(7):991-2. PubMed ID: 25124781
    [Abstract] [Full Text] [Related]

  • 20. Erdheim-Chester Disease With Cardiovascular Involvement and BRAF V600E Mutation.
    Okamura K, Suematsu Y, Morizumi S, Kawata M, Dai Y, Yamakawa M, Ono M.
    Circ J; 2016 Jun 24; 80(7):1657-9. PubMed ID: 27296272
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.